Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
$ -1.01EBITDA per Share
VS
Market
Sector
Industry
History
$ 2.2Close
$ 1.1 - $ 5.94 52-Week Range
Ticker Information
Ticker
TCRXCompany Name
TSCAN THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQTSCAN THERAPEUTICS INC - EBITDA per Share Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
TCRX - EBITDAPS Historical data
| Date | Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | EBITDA per Share | Share Factor | Weighted Average Shares |
|---|---|---|---|---|
| 6/30/2025 | $ -130.55M | $ -1.01 | 1 | 129.73M |
| 3/31/2025 | $ -124.58M | $ -0.96 | 1 | 129.68M |
| 12/31/2024 | $ -119.74M | $ -1.07 | 1 | 111.99M |
| 9/30/2024 | $ -102.91M | $ -0.87 | 1 | 118.7M |
| 6/30/2024 | $ -95.73M | $ -0.84 | 1 | 113.43M |
| 3/31/2024 | $ -87.92M | $ -0.93 | 1 | 94.88M |
| 12/31/2023 | $ -80.1M | $ -1.22 | 1 | 65.6M |
| 9/30/2023 | $ -78.88M | $ -0.83 | 1 | 94.83M |
| 6/30/2023 | $ -72.94M | $ -1.55 | 1 | 47.21M |
| 3/31/2023 | $ -65.06M | $ -2.69 | 1 | 24.23M |
Key Performance Insights, Last 5 Years
- TSCAN THERAPEUTICS INC's latest trailing twelve months (TTM) EBITDAPS stands at $ -27.18.
- Over the past 5 years, TSCAN THERAPEUTICS INC's average EBITDAPS has been $ -3.28.
- The median EBITDAPS for TSCAN THERAPEUTICS INC during this period was $ -1.38
- TSCAN THERAPEUTICS INC reached its highest EBITDAPS over the past 5 years at $ -0.83.
- The lowest EBITDAPS recorded by TSCAN THERAPEUTICS INC in the same timeframe $ -27.18
TSCAN THERAPEUTICS INC's EBITDAPS vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EBITDAPS Benchmarks
Similar metrics to Shares WA:
- EBIT per Share - [Calculation] The amount of earnings before interest and taxes attributed to each share, calculated as [EBIT] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- Book Value per Share - [Calculation] The amount of equity attributed to each share, calculated as [Equity] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- Sales per Share - [Calculation] The amount of revenue attributed to each share, calculated as [Revenue] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- Free Cash Flow per Share - [Calculation] The amount of Free Cash Flow attributed to each share, calculated as [FCF] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- Operating Cash Flow per Share - [Calculation] The amount of Operating Cash Flow attributed to each share, calculated as [NCFO] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
Definition of EBITDA per Share
[Calculation] The amount of earnings before interest, taxes, depreciation, and amortization attributed to each share, calculated as [EBITDA] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].EBITDA / (Shares WA * Share Factor)
(=) EBITDAPS EBITDAPS for TSCAN THERAPEUTICS INC is calculated as follows: EBITDA [ $ -24.9M ] / (Shares WA [ 916.01K ] * Share Factor [ 1 ])
(=) EBITDAPS [ $ -27.18 ] TCRX - EBITDA per Share, Last 5 years
$ -27.18
Minimum
Dec 31, 2020
$ -0.83
Maximum
Sep 30, 2023
$ -3.28
Average
$ -1.38
Median
EBITDAPS Benchmark AnalysisMarket
The chart above depicts the distribution of EBITDAPS for companies in the Total Stock Market. The average EBITDAPS of the companies is $ 2.03 with a standard deviation of $ 4.28.
The following table provides additional summary stats:
EBITDAPS in the Market:
| filtered constituents | 3.78K |
|---|---|
| min | $ -11.29 |
| max | $ 14.03 |
| average | $ 2.03 |
| median | $ 1 |
| std | $ 4.28 |